| Identification | Back Directory | [Name]
KRAS G12C inhibitor 5 | [CAS]
2158297-63-1 | [Synonyms]
KRAS G12C inhibitor 5
KRAS G12C inhibitor 11
KRAS G12C inhibitor 5,KRAS G-12C inhibitor 5 | [Molecular Formula]
C32H37N7O2 | [MDL Number]
MFCD31813717 | [MOL File]
2158297-63-1.mol | [Molecular Weight]
551.68 |
| Chemical Properties | Back Directory | [Boiling point ]
838.6±75.0 °C(Predicted) | [density ]
1.228±0.06 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
Soluble in DMSO | [pka]
9.31±0.40(Predicted) |
| Hazard Information | Back Directory | [Description]
KRAS G12C inhibitor 5 is a KRas G12C inhibitor extracted from patent WO2017201161A1, Compound example 147[1]. Kirsten Rat Sarcoma 2 Viral Oncogene Homolog (KRas) is a small GTPase and a member of the Ras family of oncogenes. KRas serves a molecular switch cycling between inactive (GDP -bound) and active (GTP -bound) states to transduce upstream cellular signals received from multiple tyrosine kinases to downstream effectors to regulate a wide variety of processes, including cellular proliferation[1]. | [Uses]
KRAS G12C inhibitor 5 is a KRas G12C inhibitor extracted from patent WO2017201161A1, Compound example 147[1]. | [IC 50]
KRas G12C | [storage]
Store at -20°C | [References]
[1]. John P. Fischer, et al. Kras g12c inhibitors. WO2017201161A1. |
|
| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 |
| Website: |
https://www.weikeqi-biotech.com/ |
|